BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1783360)

  • 1. Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs.
    Gosgnach M; Gérard JL; Berdeaux A; Giudicelli JF
    Fundam Clin Pharmacol; 1991; 5(8):709-18. PubMed ID: 1783360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac and hemodynamic profile of the new cardiotonic agent, DPI 201-106, in the conscious dog.
    Gerard JL; Berdeaux A; Giudicelli JF
    Eur J Pharmacol; 1989 Jun; 165(1):39-49. PubMed ID: 2767134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
    Liang CS; Thomas A; Imai N; Stone CK; Kawashima S; Hood WB
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):509-16. PubMed ID: 2447398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a novel inotropic agent, BAY y 5959, in conscious dogs: comparison with dobutamine and milrinone.
    Sato N; Uechi M; Asai K; Patrick T; Kudej RK; Vatner SF
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H753-9. PubMed ID: 9124435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
    Al-Wathiqui MH; Shimshak TM; Brooks HL; Preuss KC; Wynsen JC; Gross GJ; Warltier DC
    Pharmacology; 1988; 36(4):217-27. PubMed ID: 3380877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
    Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS
    Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of positive inotropic effects of milrinone, dobutamine and ouabain.
    Rendig SV; Amsterdam EA
    Cardiology; 1994; 84(2):99-105. PubMed ID: 8174147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milrinone versus dobutamine: contribution of altered myocardial mechanics and augmented inotropic state to improved left ventricular performance.
    Borow KM; Neumann A; Lang RM
    Circulation; 1986 Mar; 73(3 Pt 2):III153-61. PubMed ID: 3943179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain.
    Baumgart D; Ehring T; Krajcar M; Skyschally A; Heusch G
    Basic Res Cardiol; 1994; 89(1):61-79. PubMed ID: 8010937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.
    Grose R; Strain J; Greenberg M; LeJemtel TH
    J Am Coll Cardiol; 1986 May; 7(5):1107-13. PubMed ID: 3958369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of left ventricular end-systolic pressure-volume relations with an impedance catheter and transient inferior vena cava occlusion: use of this system in the evaluation of the cardiotonic effects of dobutamine, milrinone, Posicor and epinephrine.
    McKay RG; Miller MJ; Ferguson JJ; Momomura S; Sahagian P; Grossman W; Pasternak RC
    J Am Coll Cardiol; 1986 Nov; 8(5):1152-60. PubMed ID: 3760389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central and regional vascular hemodynamics following intravenous milrinone in the conscious rat: comparison with dobutamine.
    Drexler H; Höing S; Faude F; Wollschläger H; Just H
    J Cardiovasc Pharmacol; 1987 May; 9(5):563-9. PubMed ID: 2439838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood flow- and endothelium-mediated vasomotion of iliac arteries in conscious dogs.
    Young MA; Vatner SF
    Circ Res; 1987 Nov; 61(5 Pt 2):II88-93. PubMed ID: 3117408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
    Segreti JA; Marsh KC; Polakowski JS; Fryer RM
    J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure.
    Cody RJ; Müller FB; Kubo SH; Rutman H; Leonard D
    Circulation; 1986 Jan; 73(1):124-9. PubMed ID: 3940663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.
    Colucci WS
    Am J Cardiol; 1989 Jan; 63(2):17A-22A. PubMed ID: 2909993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
    Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
    Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H
    Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.